Company: ANIX
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012701
Chunk: 11

Company: Anixa Biosciences Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 8
Chunk 11
---
 1,355,000  
     2.37  

    Forfeited/expired 
     (25,000) 
     3.96  

    Options outstanding at April 30, 2025 
     12,501,094  
    $3.59  
    $692 
  
    Options exercisable at April 30, 2025 
     8,636,208  
    $3.56  
    $192 

    11

The following table summarizes
information about stock options outstanding and exercisable under the 2018 Share Plan as of April 30, 2025:

 SCHEDULE
OF OPTIONS OUTSTANDING AND EXERCISABLE

    Options Outstanding  
    Options Exercisable 
  
    Range of  Exercise Prices  
    Number  Outstanding  
    Weighted  Average  Remaining  Contractual Life  (in years)  
    Weighted  Average  Exercise Price  
    Number  Exercisable  
    Weighted  Average  Remaining  Contractual Life  (in years)  
    Weighted  Average  Exercise Price 
  
    $
    2.09 - $3.87  
     6,663,879  
     6.0  
    $3.06  
     5,338,739  
     5.1  
    $3.20 
  
    $
    4.02 - $5.30  
     5,837,215  
     7.0  
    $4.20  
     3,297,469  
     6.8  
    $4.14 

Employee Stock Purchase Plan

The Company maintains the Anixa
Biosciences, Inc. Employee Stock Purchase Plan (the “ESPP”) which permits eligible employees to purchase shares at not less
than 85% of the market value of the Company’s common stock on the offering date or the purchase date of the applicable semi-annual
offering period, whichever is lower. The ESPP was adopted by our Board of Directors on August 13, 2018 and approved by our shareholders
on September 27, 2018. During the six months ended April 30, 2025 and 2024, employees purchased 1,518 shares and 2,616 shares, respectively,
under the ESPP with aggregate